NCT00407329View on ClinicalTrials.gov

Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

January 31, 2012

Conditions
BPH
Interventions
PROCEDURE

transurethral resection of the prostate

resection of prostate

Trial Locations (1)

K7L 3J7

Centre for Advanced Urological Research, Kingston

All Listed Sponsors
lead

Queen's University

OTHER

NCT00407329 - Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter